Company name: Pharma-grade Products (MPX Bioceutical/Panaxia)
Description: Developer of smokeless pharma-grade products using cannabis.
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: North York
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: MPX Bioceutical (CSE:MPX) and Panaxia have entered into an agreement to form a joint venture as of October 10, 2018.
Number of active investors:
Profile last updated: 22-Nov-2018
Last known valuation:
Last known valuation date: